Toledano, Rafael http://orcid.org/0000-0002-9387-1088
Villanueva, Vicente
Toledo, Manuel
Sabaniego, Joel
Pérez-Domper, Paloma
Funding for this research was provided by:
Angelini Pharma
Article History
Received: 28 July 2023
Revised: 17 August 2023
Accepted: 18 August 2023
First Online: 25 August 2023
Declarations
:
: RT has received honoraria and/or research funds from Angelini Pharma, Bial, Eisai, Esteve, Jazz Pharmaceuticals and UCB Pharma. VV has received honoraria and/or research funds from Angelini Pharma, Bial, Biocodex, Eisai, Jazz Pharmaceuticals, Neuraxpharm, Novartis, Nutricia, Takeda, UCB Pharma and Xenon. MT has received honoraria and/or research funds from Angelini Pharma, Bial, Eisai, Esteve, Jazz Pharmaceuticals, Krka, Neuraxpharm, Sanofi-Aventis and UCB Pharma. PPD and JS are employees of Angelini Pharma.
: The study was approved by the Ethics Committee of the Consorci Sanitari of Terrassa and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. As BIG-PAC<sup>®</sup> is a dissociated and anonymized administrative database, the secondary data used in this study were not linked to patients’ identity and no informed consent was required.